Recent studies have shown that Epimedin B (EB) can play an anti-inflammatory role by regulating the MAPK/NF-κB/NOD signaling pathway, and EB has been shown to have the effect of treating osteoporosis (23). This evidence concerns the gene NFKB1 and osteoporosis.